4 most recent filings and news items mentioning PLUS. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/PLUS/news?limit=20"
Pull PLUS filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayePlus reported Q1 FY27 net sales of $649.1 million, down 1.5% in gross profit, driven by product mix shifts and a memory chip shortage but supported by record recurring revenue. The firm retained its fiscal 2027 full-year guidance.
View filing at SEC.gov →Plus Therapeutics Inc. has amended its certificate of incorporation to change its corporate name to Cerenome Inc. as of Aug. 3, 2026.
View filing at SEC.gov →ePlus Inc. appointed John Lutz to its Board of Directors, where he will serve on the Audit and Compensation Committees. His extensive background in global technology operations is expected to support the company's strategic oversight.
View filing at SEC.gov →ePlus achieved double-digit growth across key metrics with net sales reaching $2.44 billion and adjusted EBITDA of $204.8 million in fiscal 2026, while increasing its quarterly dividend by 8%. The company's strong execution and $411 million cash position demonstrate operational l
View filing at SEC.gov →